Wyeth’s Alavert, Protonix Sales Suffer Under Generic Pressures
This article was originally published in The Tan Sheet
Executive Summary
Sales of Wyeth's Alavert non-sedating antihistamine declined in the third quarter due to an unfavorable comparison with the product's year-ago launch period